CA Patent

CA3115355A1 — Tunable process for silica capsules/spheres preparation and their use

Assigned to Pharma In Silica Laboratories Inc · Expires 2020-04-23 · 6y expired

What this patent protects

The disclosure relates to porous and non-porous silica capsules (capsules in capsule or core-shell capsules), porous microspheres, as well as their direct phase emulsification process without surfactant and their use, wherein the particles comprise a liposoluble active/payload.

USPTO Abstract

The disclosure relates to porous and non-porous silica capsules (capsules in capsule or core-shell capsules), porous microspheres, as well as their direct phase emulsification process without surfactant and their use, wherein the particles comprise a liposoluble active/payload.

Drugs covered by this patent

Patent Metadata

Patent number
CA3115355A1
Jurisdiction
CA
Classification
—
Expires
2020-04-23
Drug substance claim
No
Drug product claim
No
Assignee
Pharma In Silica Laboratories Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.